Fuji Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Fuji Pharma has a total shareholder equity of ¥45.6B and total debt of ¥24.0B, which brings its debt-to-equity ratio to 52.6%. Its total assets and total liabilities are ¥90.0B and ¥44.4B respectively. Fuji Pharma's EBIT is ¥3.9B making its interest coverage ratio 19.8. It has cash and short-term investments of ¥4.6B.
Key information
52.6%
Debt to equity ratio
JP¥23.98b
Debt
| Interest coverage ratio | 19.8x |
| Cash | JP¥4.59b |
| Equity | JP¥45.56b |
| Total liabilities | JP¥44.44b |
| Total assets | JP¥90.00b |
Recent financial health updates
No updates
Recent updates
Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)
Nov 20
Lacklustre Performance Is Driving Fuji Pharma Co., Ltd.'s (TSE:4554) 27% Price Drop
Aug 05Fuji Pharma's (TSE:4554) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 22Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50
Jul 03Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50
Jun 19Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)
May 21Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50
May 13Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00
Feb 28Financial Position Analysis
Short Term Liabilities: 4554's short term assets (¥42.5B) exceed its short term liabilities (¥35.8B).
Long Term Liabilities: 4554's short term assets (¥42.5B) exceed its long term liabilities (¥8.6B).
Debt to Equity History and Analysis
Debt Level: 4554's net debt to equity ratio (42.6%) is considered high.
Reducing Debt: 4554's debt to equity ratio has increased from 21.3% to 52.6% over the past 5 years.
Debt Coverage: 4554's debt is not well covered by operating cash flow (17.3%).
Interest Coverage: 4554's interest payments on its debt are well covered by EBIT (19.8x coverage).